Vitamin C and E consumption and coronary heart disease in men

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 373-380

  Riccioni, Graziano ^a   Frigiola, Alessandro ^b   Pasquale, Savarese ^c   De Massimo, Girolamo ^c   D'Orazio, Nicolantonio ^c  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Cardiac ischemic disease; Coronary heart disease; Men; Prevention; Review; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; FEMALE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; VITAMIN SUPPLEMENTATION; CORONARY ARTERY DISEASE; REVIEW;

ASCORBIC ACID; CORONARY DISEASE; HUMANS; MALE; VITAMIN E;

EID: 84860849745     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e384     Document Type: Article

References (64)

1. T.A. Pearson: Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drug Ther 13,94-104 (1999)
2. th, pp. 15-36 (2004)
3. M.J. Davies, P.J. Richardson, N. Woolf, D.R. Katz, J. Mann: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69, 337-381 (1993)
4. M. Davies: Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J 16, 3-7 (1995)
5. M. Davies: The composition of coronary artery plaque. N Engl J Med 336, 1312-1313 (1997)
6. G. Riccioni, A. De Santis, V. Cerasa, V. Menna, C. Di Ilio, C. Schiavone, E. Ballone, N. D'Orazio: Atherosclerotic plaque formation and risk factors. Int J Immunopathol Pharmacol 16, 25-31 (2003)
7. R.A. Harrison, D. Holt, D.J. Pattison, P.J. Elton: Are those in need taking dietary supplements? A survey of 21923 adults. Br J Nutr 91, 617-623 (2004)
8. R.M. Krauss, R.H. Echel, B. Howard, L.J. Appel, S.R. Daniels, R.J. Deckelbaum, J.W. Jr Erdmanr, P. Kris-Etherton, I.J. Goldberg, T.A. Kotchen, A.H. Lichtenstein, W.E. Mitch, R. Mullis, K. Robinson, J. Wylie-Rosett, S. St Jeor, J. Suttie, D.L. Tribble, T.L. Bazzarre: AHA Dietary Guidelines - revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102, 2284-2299 (2000)
9. D.A. Lawlor, G. D. Smith, D. Kundu, K.R. Bruckdorfer, S. Ebrahim: Those confounded vitamins: what can we learned from the differences between observational versus randomized trial evidence? Lancet 363, 1660-1661 (2004)
10. K.G. Losonczy, T.B. Harris, R.J. Havlik: Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64, 190-196 (1996)
11. B.I. Hasnian, A.D. Mooradian: Recent trials of antioxidants therapy: what should we be telling our patients? Clev Clin J Med 71, 327-334 (2004)
12. F. Violi, L. Loffredo, L. Musella, A. Marcoccia: Should antioxidant status be considered in interventional trials with antioxidants? Heart 90, 598-602 (2004)
13. D. Behrendt, P. Ganz: Oxidative stress and vascular disease. In R. De Caterina e P. Libby (eds): Endothelial dysfunctions and vascular diseases. Blackwell Publishing pp. 148-149 (2007)
14. B. Halliwell, M. Whiteman: Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142, 231-255 (2004)
15. M. Dizdaroglu, P. Jaruga, M. Birincioglu: Free radical induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32, 1102-1115 (2002)
16. -B. Halliwell: Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic Biol Med 32, 968-974 (2002)
17. C.J.L. Murraj, A.D. Lopez: Alternative projections of mortality and disability by cause 1990-1992:Global Burden of Disease Study. Lancet 349, 1498-1503 (1997)
18. B.C. Simon, L.D. Cunningham, R.A. Cohen: Oxidized low density lipoprotein cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86, 75-79 (1990)
19. J. Li, S.P. Zhao, X.P. Li: Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 61, 165-169 (1997)
20. E. Lubos, D.E. Handy, J. Loscalzo: Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13, 5323-5344 (2008)
21. National Heart, Lung and Blood Institute. Morbidity and mortality: 1996 chartbook on cardiovascular, lung and blood diseases. Bethesda, MD, Nation al Institutes of Health (1996)
22. S. Schroder: Is the supplementation with antioxidants effective in the treatment of atherosclerosis? Med Wochenschr 129, 321-326 (2004)
23. A.C. Carr, B. Z. Zhu, B. Frei: Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha tocopherol (vitamin E). Circ Res 87,349-354 (2000)
24. J.E. Enstrom: Vitamin C intake and mortality among sample of U.S. population. Epidemiology 3,194-202 (1992)
25. W.J. Blot, J.Y. Li, H.R. Taylor, W. Guo, S. Dawsey, G.Q. Wang, C.S. Yang, S.F. Zheng, M. Gail, G.Y. Li: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 15, 1483-1492 (1993)
26. -P. Knekt, J. Ritz, M.A. Pereira, E.J. O'Reilly, K. Augustsson, G.E. Fraser, U. Goldbourt, B.L. Heitmann, G. Hallmans, S. Liu, P. Pietinen, D. Spiegelman, J. Stevens, J. Virtamo, W.C. Willett, E.B. Rimm, A. Ascherio: Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80, 1508-1520 (2004)
27. T.S. Wilson, S.B. Datta, J.S. Murrell, C.T. Andrews: Relation of vitamin C level to mortality in a geriatric hospital: a study of affect of vitamin C administration. Age Ageing 2, 163-171 (1973)
28. H.D. Sesso, J.E. Buring, W.G. Christen, T. Kurth, C. Belanger, J. MacFadyen, V. Bubes, J.E. Manson, R.J. Glynn, J.M. Gaziano: Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300, 2123-2133 (2008)
29. M. Boaz, S. Smetana, T. Weinstein, Z. Matas, U. Gafter, A. Iaina, A. Knecht, Y. Weissgarten, D. Brunner, M. Fainaru, M.S. Green: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356, 1213-1218 (2000)
30. M.N. Diaz, B. Frei, J. Vita, J. Keaney: Antioxidants and atherosclerotic heart disease. N Engl J Med 337, 408-416 (1997)
31. L.J. Machlin: Handbook of vitamins: nutritional, biochemical, and clinical aspects. 2nd ed. New york: Marcel Dekker, Inc, pp. 99-144 (1999).
32. M. Marquez, C.E. Yepez, R. Sutil-Narajo, M. Rincon: Basic aspects and measurement of the antioxidant vitamins A and E. Invest Clin 43, 191-204 (2002)
33. E. Rock, B.M. Winklhofer-Roob, J. Ribalta, M. Scotter, M.P. Vasson, J. Brtko, R. Brigelius-Flohe, A. Bronner, V. Azais-Braesco: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr Metab Cardiovasc Dis 11, 70-73 (2001)
34. A. Ong: Natural sources of tocotrienols. In Packer L, Fuchs J (Eds):Vitamin E in Health and disease. 1st edition New York: Marcel Dekker, pp 3-8(1993)
35. K. Ingold, A. Webb, D. Witter, G. Burton, T. Metcalfe, D. Muller: Vitamin E remains the major lipid soluble chain breaking antioxidant in human plasma even in individual suffering severe vitamin E deficiency. Arch Biochem Biophys 259, 224-225 (1987)
36. S. Moriguchi, M. Muraga: Vitamin E and immunity. Vitam Horm 59, 305-336 (2000)
37. M.E. Barasi: Water soluble vitamins. In: Human Nutrition. Arnold publishers, London; pp. 171-175 (1997)
38. S. Devaraj, A. Harris, I. Jialal: Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis. Nutr Rev 60, 8-14 (2002)
39. T. Yoshikawa, N. Yoshida: Vitamin E and leukocyteendothelial cell interactions. Antioxid Redox Signal 2, 821-825 (2000)
40. N. Abudu, J.J. Miller, M. Attaelmannan, S.S. Levinson: Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta 339, 11-25 (2004)
41. I. Kawachi, G. A. Colditz, A. Ascherio, E.B. Rimm, E. Giovannucci, M.J. Stampfer, W.C. Willett: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89, 1992-1997 (1994)
42. N.I. Ellis, B. Lloyd, R.S. Lloyd, B.E. Clayton: Selenium and vitamin E in relation to risk factors for coronary heart disease. J Clin Pathol 37, 200-206 (2004)
43. A. Stocker, A. Azzi: Tocopherol binding proteins: their functions and physiological significance. Antiox Redox Signal 2, 397-404 (2000)
44. I. Jalal, S. Deveraj, N. Kaul: The effect of α-tocopherol on monocyte pro-atherogenic activity. J Nutr 131,756-763 (2001)
45. S. Deveraj S, D. Li, I. Jialal: The effect of α-tocopherol supplementation on monocyte function: decrease lipid oxidation, interleukin 1β secretion and monocyte adhesion to endothelium. J Clin Invest 98, 756-763 (1996)
46. N. Ferre N, J. Camps, A. Paul, M. Cabre, L. Calleja, J. Osada, J. JovenJ: Effects of high-fat, low-cholesterol diets on hepatic lipid peroxidation and antioxidants in apolipoprotein E-deficient mice. Mol Cell Biochem 218, 165-169 (2001)
47. S. Thomas, S. Leichtweis, K. Petterson, K. Croft, T. Mori, A. Brown, R. Stocker: Dietary supplementation with vitamin E and Coenzyme Q(10) inhibit atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21, 585-593 (2001)
48. N. G. Stephens, A. Parson, P.M. Schofield, F. Kelly, K. Cheeseman, M. J. Mitchinson: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786 (1996)
49. J. M. Rapola, J. Virtam, RS. Ripatti, J.K. Huttunen, D. Albanes, P.R. Taylor, O.P. Heinonen: Alpha Tocopherol Beta Carotene Cancer Prevention Study (ATBC): Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous MI. Lancet 349, 1715-1720 (1997)
50. E.B. Rimm, M.I. Stampfer, A. Ascherio, E. Giovannucci, G.A. Colditz, B. Rosner, W.C. Willet: Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 328,1450-1456 (1993)
51. R. Weinberg, B. Vander-Werken, R. Anderson, J. Stegner, M. Thomas: Pro-oxidant effects of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol 21, 1029-1033 (2001)
52. E. Negri, C. La Vecchia, A. Nobili, B. D'Avanzo, S. Bechi: Cigarette smoking and acute myocardial infarction. A case-control study from the GISSI-2 trial. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'infarto Miocardico. Eur J Epidemiol 10, 361-366 (1994)
53. The Hearth Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high risk patients. N Eng J Med 342, 154-160 (2000)
54. G. De Gaetano: Low dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of Primary Prevention Project. Lancet 357, 89-95 (2001)
55. M.E. Keith, K.N. Jeejeebhoy, A. Langer, A. Barr, B. O'Kelly, M.J. Sole: A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 73, 219-224 (2001)
56. Heart Protection Study Collaborative Group MRC/BHF Heart protection study of antioxidant vitamin supplementation in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33 (2002)
57. A-C. Kaliora, G.V. Dedoussis, H. Schmidt: Dietary antioxidants in preventing atherogenesis. Atherosclerosis 187, 1-17 (2006)
58. U.S. Preventive Services Task Force: Routine vitamin supplementation to prevent cancer and cardiovascular disease. Nutr Clin Care 6, 102-107 (2003)
59. S.A. Stanner, J. Hughes, C.N. Kelly, J. Buttriss: A review of the epidemiological evidence for the "antioxidant hypothesis". Public Health Nutr 24, 407-422 (2004)
60. Z. Ye, H. Song: Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 15, 26-34 (2008)
61. J.M. Morillas-Ruiz, J.A. Villegas Garcia, F.J. Lopez, M.L. Vidal-Guevara, P. Zafrilla: Effects of polyphenolic antioxidants on exercise-induced oxidative stress. Clin Nutr 25, 444-453 (2006)
62. P.M. Kris-Etherton, M. Lefevre, G.R. Beecher, M.D. Gross, C.L. Keen, T.D. Etherton: Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and antiinflammatory effects of flavonoids on atherosclerosis. Ann Rev Nutr 24, 511-538 (2004)
63. I. Juranek, S. Bezek: Controversy of free radical hypothesis: reactive oxygen species - cause or consequence of tissue injury? Gen Physiol Biophys 24, 263-278 (2005)
64. G. Riccioni: Carotenoids and cardiovascular diseases. Curr Atheroscler Rep 11, 434-439 (2009)